1. 111 Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P301) Assessing Efficacy and Safety of Extended-Release Viloxazine in Children with ADHD. (April 2020) Authors: Nasser, Azmi; Hull, Joseph T.; Chowdhry, Fatima A.; Adewole, Toyin; Liranso, Tesfaye; Schwabe, Stefan Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 112 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P302): Efficacy and Safety of Extended-Release Viloxazine in Adolescents with ADHD. (April 2020) Authors: Nasser, Azmi; Hull, Joseph T.; Chowdhry, Fatima A.; Adewole, Toyin; Liranso, Tesfaye; Schwabe, Stefan Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 113 Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P303) Assessing Efficacy and Safety of Extended-Release Viloxazine in Children with ADHD. (April 2020) Authors: Nasser, Azmi; Hull, Joseph T.; Chowdhry, Fatima A.; Adewole, Toyin; Liranso, Tesfaye; Schwabe, Stefan Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 114 An Assessment of QTc Effects With SPN-812 (Extended-Release Viloxazine) in Healthy Adults. (April 2020) Authors: Nasser, Azmi; Faison, Shamia L.; Liranso, Tesfaye; Adewole, Toyin; Fava, Maurizio; Kleiman, Robert; Schwabe, Stefan Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 9 Phase 3 Randomized, Double-blind, Placebo-Controlled Studies Evaluating Efficacy and Safety of Extended-Release Viloxazine for Pediatric ADHD. (12th March 2019) Authors: Nasser, Azmi; Johnson, Janet K.; Adewole, Toyin; Liranso, Tesfaye; Marcus, Ronald Journal: CNS spectrums Issue: Volume 24:Number 1(2019:Feb) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Double-Blind, Randomized Study of Extended-Release Molindone for Impulsive Aggression in ADHD. Issue 11 (September 2021) Authors: Ceresoli-Borroni, Gianpiera; Nasser, Azmi; Adewole, Toyin; Liranso, Tesfaye; Xu, Jiahong; Schwabe, Stefan; Findling, Robert L. Journal: Journal of attention disorders Issue: Volume 25:Issue 11(2021) Page Start: 1564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder. Issue 4 (July 2021) Authors: Nasser, Azmi; Liranso, Tesfaye; Adewole, Toyin; Fry, Nicholas; Hull, Joseph T.; Busse, Gregory D.; Chowdhry, Fatima; Cutler, Andrew J.; Jones, Nandita Joshi; Findling, Robert L.; Schwabe, Stefan Journal: Journal of clinical psychopharmacology Issue: Volume 41:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD. Issue 2 (January 2020) Authors: Johnson, Janet K.; Liranso, Tesfaye; Saylor, Keith; Tulloch, Gabriela; Adewole, Toyin; Schwabe, Stefan; Nasser, Azmi; Findling, Robert L.; Newcorn, Jeffrey H. Journal: Journal of attention disorders Issue: Volume 24:Issue 2(2020) Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effects of Viloxazine ER (Qelbree®) on Weight and Height Trajectories: Interim Results From a Long-term, Open-Label Extension Trial in Pediatric ADHD. (April 2023) Authors: Nasser, Azmi; Hull, Joseph; Earnest, Jami; Koch, Jennifer; Liranso, Tesfaye; Maldonado-Cruz, Zulane; Rubin, Jonathan; Childress, Ann Journal: CNS spectrums Issue: Volume 28:Number 2(2023) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended‐release in children and adolescents with attention‐deficit/hyperactivity disorder. Issue 8 (26th May 2021) Authors: Nasser, Azmi; Kosheleff, Alisa R.; Hull, Joseph T.; Liranso, Tesfaye; Qin, Peibing; Busse, Gregory D.; Fava, Maurizio; Maletic, Vladimir; Rubin, Jonathan; Lopez, Frank Journal: International journal of clinical practice Issue: Volume 75:Issue 8(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗